Categories: India

BRIEF-Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 – SEC Filing

Sept 21 (Reuters) – Recursion Pharmaceuticals, Inc. : * RECURSION PHARMACEUTICALS – ENTERS AMENDMENT TO MASTER AGREEMENT WITH TEMPUS ON SEPT 15, 2026 – SEC FILING * RECURSION PHARMACEUTICALS – EXTENDS

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

PARAMOUNT SKYDANCE CORP. HAS REACHED A SETTLEMENT WITH CALIFORNIA AND OTHER STATES SUING TO BLOCK ITS PROPOSED ACQUISITION OF WARNER BROS. DISCOVERY INC. – BLOOMBERG NEWS

PARAMOUNT SKYDANCE CORP. HAS REACHED A SETTLEMENT WITH CALIFORNIA AND OTHER STATES SUING TO BLOCK…

43 seconds ago

Spain extend De la Fuente contract until 2032 after World Cup triumph

VIDEO SHOWS: COMMENTS FROM SPAIN COACH LUIS DE LA FUENTE DURING CONTRACT RENOVATION EVENT, FILE…

3 minutes ago

BRIEF-Openai And Anthropic Neared Deal To Stress-Test Each Other's AI Earlier This Year – The Information

Sept 21 (Reuters) - * OPENAI AND ANTHROPIC NEARED DEAL TO STRESS-TEST EACH OTHER’S AI…

5 minutes ago

Warner Bros, Paramount rise on report California settlement talks could clear merger hurdle

Sept 21 (Reuters) - Shares of Warner Bros Discovery and Paramount Skydance jumped on Monday,…

7 minutes ago

Irish privacy regulator fines Google €403 million over location data processing

By Padraic Halpin DUBLIN, Sept 21 (Reuters) - The lead EU data privacy regulator for…

9 minutes ago